Serial Number | 88138951 |
Word Mark | NUMBERS MATTER |
Filing Date | Monday, October 1, 2018 |
Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
Status Date | Monday, July 11, 2022 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, April 9, 2019 |
Goods and Services | Pharmaceutical preparations for the treatment of immuno oncological disorders, cancer, diabetes, respiratory, heart, neurological and auto immune disorders; stem cells for medical purposes; living cells for medical use; biological preparations for the treatment of cancer; therapeutic pharmaceuticals utilizing neural crest cells for use in the treatment of cancer, autoimmune disease and infectious diseases; Cell preparations, cellular vaccines and cellular biologics for the treatment of cancer and infectious diseases by autologous cell-based immunotherapy |
Goods and Services | Medical testing for diagnostic or treatment purposes in the field of cancer research; medical diagnostic testing, monitoring and reporting services; medical evaluation of immuno oncological disorders, cancer, diabetes, respiratory, heart, neurological and auto immune disorders; medical monitoring services; medical diagnostic, prognostic and theranostic screening and testing services; collection and preservation of dna for medical purposes; consulting services in the nature of providing medical information; consulting services in the field of healthcare and cancer diagnoses; providing a website featuring health and healthcare information related to cancer, testing and screening; genetic testing for medical purposes; providing information in the field of cancer prevention, screening, diagnosis and treatment for medical diagnostic and treatment purposes; providing genetics assessments in the nature of genetic counseling; genetic testing for medical diagnostic purposes; genomic testing for medical diagnostic purposes; Gene analysis and sequencing and DNA analysis and sequencing for medical diagnostic purposes and veterinary diagnostics purposes; gene analysis and sequencing and DNA analysis and sequencing for use in cancer diagnosis and treatment; providing a website featuring health and healthcare information related to cancer research |
Goods and Services | Scientific and technological services, namely, scientific research, design, analysis and testing in the field of cancer evolution and new cancer therapies using natural killer cells; industrial research in the field of new pharmaceutical products and new cancer therapies; medical and veterinary research services in the nature of the manipulation of cells within a laboratory or research facility to enable natural killer cells to be used for medical or therapeutic purposes; scientific research in the development of new cancer therapies; scientific research in human and animal cell therapy; scientific research into preparations for manipulating and adapting human and animal cells; consultancy relating to all the aforesaid services; Conducting research and clinical trials for others relating to the use and the engineering of natural killer cells and cancer treatment and therapy; medical and scientific research in the field of cancer treatment and diagnosis; data collection for others for research purposes, namely, the collection, testing and research of patient molecular and genomic data; collection and preservation of human and animal DNA for research purposes |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, October 10, 2018 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, October 10, 2018 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, October 10, 2018 |
Primary Code | 044 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | KIADIS PHARMA INTELLECTUAL PROPERTY B.V. |
Party Type | 21 - New Owner After Publication |
Legal Entity Type | 26 - NOT AVAILABLE |
Address | AMSTERDAM 1105BP NL |
Party Name | CytoSen Therapeutics, Inc. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | Winter Springs, FL 32708 |
Party Name | CytoSen Therapeutics, Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Winter Springs, FL 32708 |
Event Date | Event Description |
Monday, July 11, 2022 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
Monday, July 11, 2022 | ABANDONMENT - NO USE STATEMENT FILED |
Wednesday, December 1, 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Tuesday, November 30, 2021 | SOU EXTENSION 5 GRANTED |
Monday, November 22, 2021 | SOU EXTENSION 5 FILED |
Tuesday, November 30, 2021 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
Monday, November 22, 2021 | SOU TEAS EXTENSION RECEIVED |
Wednesday, November 17, 2021 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
Wednesday, November 17, 2021 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Wednesday, November 17, 2021 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
Wednesday, November 17, 2021 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
Wednesday, November 17, 2021 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Wednesday, November 17, 2021 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Wednesday, November 17, 2021 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
Thursday, May 20, 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Tuesday, May 18, 2021 | SOU EXTENSION 4 GRANTED |
Tuesday, May 18, 2021 | SOU EXTENSION 4 FILED |
Tuesday, May 18, 2021 | SOU TEAS EXTENSION RECEIVED |
Wednesday, December 23, 2020 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
Saturday, December 5, 2020 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Thursday, December 3, 2020 | SOU EXTENSION 3 GRANTED |
Thursday, December 3, 2020 | SOU EXTENSION 3 FILED |
Thursday, December 3, 2020 | SOU TEAS EXTENSION RECEIVED |
Thursday, June 4, 2020 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Tuesday, June 2, 2020 | SOU EXTENSION 2 GRANTED |
Tuesday, June 2, 2020 | SOU EXTENSION 2 FILED |
Tuesday, June 2, 2020 | SOU TEAS EXTENSION RECEIVED |
Friday, December 6, 2019 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Wednesday, December 4, 2019 | SOU EXTENSION 1 GRANTED |
Wednesday, December 4, 2019 | SOU EXTENSION 1 FILED |
Wednesday, December 4, 2019 | SOU TEAS EXTENSION RECEIVED |
Tuesday, June 4, 2019 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Tuesday, April 9, 2019 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, April 9, 2019 | PUBLISHED FOR OPPOSITION |
Wednesday, March 20, 2019 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, March 5, 2019 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Tuesday, March 5, 2019 | EXAMINER'S AMENDMENT ENTERED |
Tuesday, March 5, 2019 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
Tuesday, March 5, 2019 | EXAMINERS AMENDMENT E-MAILED |
Tuesday, March 5, 2019 | EXAMINERS AMENDMENT -WRITTEN |
Monday, March 4, 2019 | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
Tuesday, February 26, 2019 | WITHDRAWN FROM PUB - OG REVIEW QUERY |
Wednesday, February 13, 2019 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
Wednesday, February 13, 2019 | ASSIGNED TO LIE |
Monday, January 28, 2019 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Wednesday, January 23, 2019 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Tuesday, January 22, 2019 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Tuesday, January 22, 2019 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Tuesday, November 20, 2018 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Tuesday, November 20, 2018 | NON-FINAL ACTION E-MAILED |
Tuesday, November 20, 2018 | NON-FINAL ACTION WRITTEN |
Thursday, November 8, 2018 | ASSIGNED TO EXAMINER |
Wednesday, October 10, 2018 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Thursday, October 4, 2018 | NEW APPLICATION ENTERED |